This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2015, 11, 155–161, doi:10.3762/bjoc.11.15
Graphical Abstract
Scheme 1: Reagents and conditions: (A) p-thiocresol, BF3∙Et2O, CH2Cl2, 24 h, rt, 81%; (B) i) NaOMe, MeOH, 12 ...
Figure 1: Degradation of 4’F-TF antigen derivative 12 and its natural (synthetic) congener 13 by β-galactosid...
Scheme 2: Reagents and conditions: (A) aq Na2CO3, pH 8.0, EtOH/H2O (1:1); (B) aq Na2HPO4, pH 9.5, 5 d.
Figure 2: ELISA of the antiserum of mouse 2 induced by 4’F-TF-Thr6-MUC1(20)-TTox vaccine 18b; coat: 5 µg/mL 4...
Figure 3: Determination of the isotypes of the antibodies induced by 4’F-TF-Thr6-MUC1(20)-TTox vaccine 18b (a...
Figure 4: FACS analysis of the binding of MCF-7 tumor cells by the antiserum of mouse 2 induced by vaccinatio...
Beilstein J. Org. Chem. 2010, 6, No. 47, doi:10.3762/bjoc.6.47
Figure 1: Structures of the naturally occurring TN and TF antigens and the targeted Fmoc-β3hThr analogues.
Scheme 1: Synthesis of Fmoc-β3hThr antigen conjugates by Arndt–Eistert homologation.
Scheme 2: Solid-phase synthesis of the tumour-associated MUC1 α/β-hybrid glycopeptide analogue 8 carrying the...